Page 3 - Harmony Bioscience News Today

Equities research analysts predict that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) will post earnings of $0.40 per share for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Harmony Biosciences’ earnings, with the lowest EPS estimate coming in at $0.30 and the highest estimate coming in at $0.45. Harmony […]

Enochian Biosciences (NASDAQ:ENOB – Get Rating) and Harmony Biosciences (NASDAQ:HRMY – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability and earnings. Institutional & Insider Ownership 4.7% of Enochian Biosciences shares are […]

Analysts expect Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) to report earnings per share of $0.40 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Harmony Biosciences’ earnings, with estimates ranging from $0.30 to $0.45. Harmony Biosciences reported earnings per share of $0.54 during the same quarter […]

PTC Therapeutics (NASDAQ:PTCT – Get Rating) and Harmony Biosciences (NASDAQ:HRMY – Get Rating) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Volatility and Risk PTC Therapeutics has a beta of […]

HRMY earnings call for the period ending March 31, 2022.

Analysts expect that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) will post sales of $87.77 million for the current quarter, Zacks reports. Four analysts have made estimates for Harmony Biosciences’ earnings, with the highest sales estimate coming in at $88.80 million and the lowest estimate coming in at $86.88 million. Harmony Biosciences posted sales […]

Brokerages predict that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) will announce earnings per share (EPS) of $0.25 for the current quarter, Zacks reports. Four analysts have made estimates for Harmony Biosciences’ earnings, with estimates ranging from $0.15 to $0.30. Harmony Biosciences reported earnings per share of $0.38 in the same quarter last year, […]

Equities research analysts expect that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) will report sales of $87.77 million for the current quarter, Zacks reports. Four analysts have provided estimates for Harmony Biosciences’ earnings, with estimates ranging from $86.88 million to $88.80 million. Harmony Biosciences reported sales of $59.67 million in the same quarter last […]

Wall Street brokerages predict that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) will post sales of $87.77 million for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Harmony Biosciences’ earnings, with the highest sales estimate coming in at $88.80 million and the lowest estimate coming in at $86.88 […]

Wall Street analysts predict that Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Rating) will announce $0.25 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Harmony Biosciences’ earnings, with estimates ranging from $0.15 to $0.30. Harmony Biosciences posted earnings of $0.38 per share during the same […]